Jamil Rehman • 1981 • Oslo • 19 roles • 21 shareholdings

Roles

Name	Role	Total operating income	Total equity	Shares
P PHARMESA AS	Managing Director/CEO	-	191,998	32.5 % indirectly
S SHV1 AS Under liquidation	Managing Director/CEO	-	335,580	21.68 % indirectly

Name	Role	Total operating income	Total equity	Shares
M MSZ INVEST AS	Chairman	-	1,533,848	100 % directly
S STOROSLO ENTREPRENØR AS	Chairman	27,362,247	-5,623,467	65 % indirectly
M MSZ EIENDOM AS	Chairman	261,000	-696,180	65 % indirectly
A APRIKOS VENTURE AS	Chairman	89,172	-2,371,234	65 % indirectly
N NORDIC LEGACY AS	Chairman	52,250	-8,750,291	65 % indirectly
B BALDERX AS	Chairman	-	-988,408	60.45 % indirectly
D DKV5 AS	Chairman	40,500,000	-13,826,313	58.5 % indirectly
U UNITAS INVEST AS	Chairman	-	1,366,644	50.5 % indirectly
S SHIPPINGX AS	Chairman	-	6,374,618	49.5 % indirectly
J JUNI AI AS	Chairman	605,777	-2,593,281	45.5 % indirectly
A ANTEK AS Under liquidation	Chairman	13,980,266	-1,444,109	33.15 % indirectly
G GARDERBAKKEN 27 AS	Chairman	-	164,439	33.15 % indirectly
P PHARMESA AS	Chairman	-	191,998	32.5 % indirectly
S SHV1 AS Under liquidation	Chairman	-	335,580	21.68 % indirectly
N NOVEMBER PROPERTY AS	Chairman	-	-7,757,463	13.87 % indirectly
M MKV 32 AS	Chairman	-	10,542,540	13.87 % indirectly
R REHMANS EIENDOM AS	Alternate Member	12,750,000	9,084,657	-

Last update: Oct 12, 2026

Name	Share class	Total operating income	Total equity	Share
M MSZ INVEST AS	Ordinære aksjer	0	1,533,848	100 % directly
S STOROSLO ENTREPRENØR AS		27,362,247	-5,623,467	65 % indirectly
M MSZ EIENDOM AS		261,000	-696,180	65 % indirectly
A APRIKOS VENTURE AS		89,172	-2,371,234	65 % indirectly
N NORDIC LEGACY AS		52,250	-8,750,291	65 % indirectly
B BALDERX AS		0	-988,408	60.45 % indirectly
D DKV5 AS		40,500,000	-13,826,313	58.5 % indirectly
U UNITAS INVEST AS		0	1,366,644	50.5 % indirectly
S SHIPPINGX AS		0	6,374,618	49.5 % indirectly
J JUNI AI AS		605,777	-2,593,281	45.5 % indirectly
A ANTEK AS Under liquidation		13,980,266	-1,444,109	33.15 % indirectly
G GARDERBAKKEN 27 AS		0	164,439	33.15 % indirectly
P PHARMESA AS		0	191,998	32.5 % indirectly
A APRIKOS MEDICAL AS		43,408	-6,674,664	22.97 % indirectly
S SHV1 AS Under liquidation		0	335,580	21.68 % indirectly
N NOVEMBER PROPERTY AS		0	-7,757,463	13.87 % indirectly
M MKV 32 AS		0	10,542,540	13.87 % indirectly
H HWH SKJOLDVEIEN AS Closed		0	24,431	9.1 % indirectly
H HWH HARTMANN AS		0	0	9.1 % indirectly
H HWH KAPITAL AS		0	2,451,257	6.5 % indirectly
H HWH EIENDOM AS		1,840,000	0	1.15 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Oct 30, 2026